首页 | 本学科首页   官方微博 | 高级检索  
检索        

“10~23”型脱氧核酶的研究进展
引用本文:洪洁华,刘晓波,吕小迅.“10~23”型脱氧核酶的研究进展[J].国际药学研究杂志,2007,34(2):99-102.
作者姓名:洪洁华  刘晓波  吕小迅
作者单位:广东药学院基础学院微生物学教研室,广东,广州,510006
基金项目:广东省医学科学技术研究基金
摘    要:脱氧核酶是利用体外分子进化技术获得的一种具有酶活性的单链DNA分子。迄今为止,利用该技术已筛选出多种具有催化功能的脱氧核酶分子,其中研究最多的是具有RNA切割活性的脱氧核酶,尤其是10~23型脱氧核酶,该酶能催化RNA特定部位的切割反应,从mRNA水平使基因灭活,从而调控蛋白质的表达,在抗肿瘤、抗病毒等基因治疗领域具有广阔的应用前景。

关 键 词:脱氧核酶  体外筛选  基因灭活  基因治疗
文章编号:1001-0971(2007)02-0099-04
收稿时间:2006-10-16
修稿时间:2006年10月16

Progress in the research on "10-23"deoxyribozyme
HONG Jie-hua,LIU Xiao-bo.Progress in the research on "10-23"deoxyribozyme[J].Foreign Medical Sciences(Section of Pharmarcy),2007,34(2):99-102.
Authors:HONG Jie-hua  LIU Xiao-bo
Institution:(Department of Microbiology, School of Basic Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China)
Abstract:Deoxyribozyme is a single-stranded molecule with enzymatic activity. It was derived from a random sequence DNA pool by in vitro selection. Up to date, a variety of deoxyribozymes have been isolated in vitro that can catalyze different chemical reactions. Of particular interest are deoxyribozymes with RNA-cleaving activity, especially “10-23” DNAzyme. It can cleave any RNA in a sequence-specific manner and inactivate gene at the level of mRNA,then regulate the expression of protein. So it may have a wide application prospect in gene therapy as anti cancer and anti viral agents and so on.
Keywords:deoxyribozyme  in vitro selection  gene inactivation  gene therapy
本文献已被 万方数据 等数据库收录!
点击此处可从《国际药学研究杂志》浏览原始摘要信息
点击此处可从《国际药学研究杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号